Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study

CompletedOBSERVATIONAL

Enrollment

1,371,146

Participants

Timeline

Start Date

November 15, 2019

Primary Completion Date

April 14, 2020

Study Completion Date

April 14, 2020

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium bromide + Olodaterol

DEVICE

Sp(t)iolto® Respimat®

Trial Locations (1)

AETION inc, New York